Evergreen Nephrology, a leader in value-based kidney care, announced it has raised $130 million in capital to expand its care model to more patients living with kidney disease. This funding was led by Rubicon Founders, Oak HC/FT and a group of existing investors, with the addition of K2 HealthVentures.
The funding will advance Evergreen’s growth by enabling its expansion into new regions while implementing advanced technologies to improve clinical outcomes, streamline care delivery, and ease the administrative burden on nephrologists.
There are tens of millions of Americans living with chronic kidney disease, and Medicare spending exceeds tens of billions annually. And Evergreen’s value-based care approach addresses a critical need to transform how kidney disease is managed.
Evergreen Nephrology takes a collaborative approach to kidney care by working closely with nephrologists to enhance patient outcomes. The organization offers nephrologists wraparound support through analytical insight and tools, as well as a dedicated care team for their patients consisting of nurse care managers, care coordinators, social workers, dietitians, and pharmacists. The interdisciplinary model ensures that patients receive holistic and personalized care while enabling nephrologists to focus on their clinical expertise and leadership in managing kidney disease.
Ropes & Gray served as Evergreen’s legal counsel for the deal.
KEY QUOTES:
“This investment enables us to broaden access to care programs that improve patient outcomes while driving down healthcare costs. We are dedicated to creating lasting, positive change for patients and families affected by chronic kidney disease.”
– John Donlan, Chief Executive Officer of Evergreen Nephrology
“The healthcare system has long overlooked the critical need to empower nephrologists in the delivery of advanced kidney care management. By equipping nephrologists with the tools, resources, and support they need, Evergreen is bridging a crucial gap in healthcare and enabling a more effective, collaborative approach to managing kidney disease.”
– Matt Kim, Partner at Rubicon and Co-Founder of Evergreen Nephrology
